Inovio Pharmaceuticals Inc (NASDAQ:INO)

8.50
Data as of Jan 28
 -0.44 / -4.92%
Today’s Change
7.48
Today|||52-Week Range
15.80
-7.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues1.7M2.4M3.8M0.00
 
 
 
 
 
Operating ExpensesGross Income-------419.3K
 
 
Total Operating Expenses10.7M12.4M14.0M10.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.0M-10.0M-10.2M-10.2M
 
 
 
 
 
Extraordinary Credit----824.4K--
 
 
Extraordinary Charge-7.5M-505.9K0.00-114.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M-10.8M-10.7M-7.2M
 
 
 
 
 
Minority Interest-13.5K-9.4K-6.4K-1.5K
 
 
 
 
 
Net Income-15.5M-10.8M-10.7M-7.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.1M55.2M60.2M60.4M
 
 
 
 
 
Shares To Calculate EPS Diluted52.1M55.2M60.2M60.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.20-$0.19-$0.12
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.